# PFE Stock Analysis Report
**Pfizer, Inc.** - Comprehensive Analysis
Generated: 2026-04-30 10:22 ET | Data delay: 15min

---

## Recommendation: AVOID / WAIT

**Strengths:**
- Attractive valuation (Fwd P/E 9.5x)
- Attractive dividend (6.5%)

**Risks:**
- Weak/no trend (score 0.6/8)
- Fair PMCC viability (2.5/11)
- High payout ratio (126%)
- Revenue declining (-1.2%)

---

## Company Overview

| Metric | Value |
|--------|-------|
| Company | Pfizer, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | $152.4B |
| Enterprise Value | $203.7B |
| Beta | 0.39 |

---

## Trend Analysis

| Indicator | Value | Signal |
|-----------|-------|--------|
| Bullish Score | 0.57 / 8 | Bearish |
| Price | $26.79 | - |
| 3-Month Return | +1.3% | Bullish |
| vs SMA20 | -1.3% | Below |
| vs SMA50 | -1.3% | Below |
| RSI | 46.9 | Neutral |
| MACD | -0.18 vs Signal -0.09 | Bearish |
| ADX | 14.7 | Weak Trend |
| Next Earnings | 2026-05-05 | BMO |

**Signals:**
- RSI neutral (46.9)

---

## Fundamental Analysis

### Valuation

| Metric | Value | Assessment |
|--------|-------|------------|
| Trailing P/E | 19.7x | Reasonable |
| Forward P/E | 9.5x | Attractive |
| Price/Book | 1.76x | - |
| EPS (TTM) | $1.36 | - |
| Forward EPS | $2.81 | - |

### Profitability

| Metric | Value | Assessment |
|--------|-------|------------|
| Profit Margin | 12.4% | Good |
| Operating Margin | 23.9% | Excellent |
| ROE | 8.9% | Low |
| ROA | 5.7% | - |
| Revenue Growth | -1.2% | Declining |
| Earnings Growth | N/A | - |

### Dividend & Balance Sheet

| Metric | Value | Assessment |
|--------|-------|------------|
| Dividend Yield | 6.55% | High |
| Dividend Rate | $1.72/share | - |
| Payout Ratio | 126% | At limit |
| Debt/Equity | 78.0% | Moderate |
| Current Ratio | 1.16x | Adequate |

### Earnings History

| Date | Estimate | Actual | Surprise |
|------|----------|--------|----------|
| 2026-05-05 | $0.72 | - | - |
| 2026-02-03 | $0.57 | $0.66 | +16.2% |
| 2025-11-04 | $0.63 | $0.87 | +37.4% |
| 2025-08-05 | $0.57 | $0.78 | +35.9% |
| 2025-04-29 | $0.67 | $0.92 | +36.5% |
| 2025-02-04 | $0.46 | $0.63 | +37.2% |
| 2024-10-29 | $0.61 | $1.06 | +73.3% |
| 2024-07-30 | $0.46 | $0.60 | +30.2% |

*Consistent and significant beats over 7 straight quarters.*

---

## Piotroski F-Score

**Score: 6 / 9** (Good - Strong financial health)

| # | Criteria | Result | Details |
|---|----------|--------|---------|
| 1 | Positive Net Income | PASS | $7.77B |
| 2 | Positive ROA | PASS | 3.7% |
| 3 | Positive Operating CF | PASS | $11.70B |
| 4 | CF > Net Income | PASS | CF: $11.70B vs NI: $7.77B |
| 5 | Lower Long-Term Debt | FAIL | Recent: $60.8B, Prev: $56.7B |
| 6 | Higher Current Ratio | FAIL | Recent: 1.160, Prev: 1.171 |
| 7 | No Share Dilution | FAIL | Recent: 9.621B shares, Prev: 9.593B |
| 8 | Higher Gross Margin | PASS | Recent: 74.3%, Prev: 71.9% |
| 9 | Higher Asset Turnover | PASS | Recent: 0.301, Prev: 0.298 |

---

## Insider Trading Activity

**Net Sentiment: Neutral**

| Metric | Value |
|--------|-------|
| Buys (90 days) | 0 transactions, $0 total |
| Sells (90 days) | 0 transactions, $0 total |
| Net Activity | $0 |

### Recent Transactions

| Date | Insider | Role | Transaction | Shares | Price | Value | Own |
|------|---------|------|-------------|--------|-------|-------|-----|
| 2026-03-03 | DAMICO JENNIFER B. | Officer | Other | 21,719 | - | - | D |
| 2026-02-25 | BOURLA ALBERT | Chief Executive Officer | Exercise | 491,626 | $33.82 | $16,626,791 | D |
| 2026-02-25 | DAMICO JENNIFER B. | Officer | Exercise | 17,558 | $33.82 | $593,812 | D |
| 2026-02-25 | SAHNI PAYAL | Officer | Exercise | 56,888 | $33.82 | $1,923,952 | D |
| 2026-02-25 | MCDERMOTT MICHAEL | Officer | Exercise | 37,925 | $33.82 | $1,282,624 | D |
| 2026-02-25 | BOSHOFF CHRISTOFFEL | Officer | Other | 13,383 | - | - | D |
| 2026-02-25 | FONSECA LIDIA PH.D. | Officer | Exercise | 56,888 | $33.82 | $1,923,952 | D |
| 2026-02-25 | LANKLER DOUGLAS M | Officer | Exercise | 122,907 | $33.82 | $4,156,715 | D |

*All recent activity is option exercises (likely at-the-money or in-the-money), not open-market buys. No directional signal.*

---

## PMCC Viability

| Metric | Value | Assessment |
|--------|-------|------------|
| PMCC Score | 2.5 / 11 | Poor |
| Implied Volatility | 23.0% | Low (<25%) |
| LEAPS Expiry | 2027-03-19 (322 days) | - |
| LEAPS Strike | $23.00 | - |
| LEAPS Delta | 0.857 | Off Target (high) |
| LEAPS Bid/Ask | $3.95 / $4.45 | - |
| LEAPS Spread | 11.9% | Acceptable |
| Short Expiry | 2026-05-08 (7 days) | - |
| Short Strike | $28.00 | - |
| Short Delta | 0.154 | On Target |
| Short Bid/Ask | $0.08 / $0.12 | - |
| Short Spread | 40.0% | Wide |

### Trade Metrics

| Metric | Value |
|--------|-------|
| Net Debit | $420.00 |
| Short Yield (per cycle) | 2.38% |
| Estimated Annual Yield | 124.1% |
| Max Profit (if assigned) | $222.00 |
| ROI at Max Profit | 52.9% |
| Capital Required | $420.00 |

*Note: The wide short spread (40%) and very low short premium ($0.10 mid) make execution challenging. Annual yield estimate is unrealistic at this premium level.*

---

## Option Spread Strategies

**Expiry:** 2026-06-05 (36 DTE) | Underlying: $26.79

### Strategy Summary

| Strategy | Direction | Max Profit | Max Loss | Risk/Reward | Breakeven |
|----------|-----------|------------|----------|-------------|-----------|
| Bull Call Spread | Bullish | $168 | $32 | 5.25x | $27.32 |
| Bear Put Spread | Bearish | $102 | $98 | 1.04x | $26.02 |
| Long Straddle | Neutral | Unlimited | $181 | - | $25.20 / $28.80 |
| Long Strangle | Neutral | Unlimited | $51 | - | $24.50 / $29.50 |
| Iron Condor | Neutral | -$11 | $211 | N/A | $25.11 - $28.89 |

> **Iron Condor shows negative credit** — not executable at current spreads. Skip.

### Strategy Details

**Bull Call Spread** (Bullish)
- Long $27 call / Short $29 call
- Net debit: $0.32 ($32 total)
- Breakeven: $27.32 (+2.0% move needed)
- Max profit: $168 at $29+
- Risk/Reward: 5.25x

**Bear Put Spread** (Bearish)
- Long $27 put / Short $25 put
- Net debit: $0.98 ($98 total)
- Breakeven: $26.02 (-2.9% move needed)
- Max profit: $102 at $25 or below
- Risk/Reward: 1.04x

**Long Straddle** (Neutral — expects big move)
- Long $27 call + Long $27 put
- Total cost: $1.81 ($181 total)
- Needs ±6.7% move to profit
- Upside breakeven: $28.80 | Downside: $25.20
- *Earnings on 2026-05-05 may catalyze the move*

**Long Strangle** (Neutral — lower cost)
- Long $29 call + Long $25 put
- Total cost: $0.51 ($51 total)
- Upside breakeven: $29.50 | Downside: $24.50

**Iron Condor** — Not recommended (negative credit)

---

## Investment Summary

**Strengths:**
- Attractive valuation: Forward P/E of 9.5x suggests significant upside if earnings trajectory holds
- High dividend yield (6.5%) provides income while waiting for catalyst
- Consistent earnings beats — 7 straight quarters, average surprise ~35%
- Solid Piotroski F-Score of 6/9, strong cash flow generation ($11.7B OCF)
- Low beta (0.39) — defensive stock with limited market correlation

**Risk Factors:**
- No trend: Bullish score 0.57/8 — stock is in no-man's land below both SMA20 and SMA50
- Unsustainable dividend: Payout ratio of 126% exceeds net income; funded by cash/debt
- Revenue declining (-1.2%) — top-line pressure despite earnings beats
- Long-term debt rising ($60.8B vs $56.7B prior year)
- Earnings risk: Q1 2026 report on 2026-05-05 (BMO) — consensus at $0.72
- PMCC impractical: Low IV, wide short spreads, thin LEAPS liquidity
- No open-market insider buying despite depressed price levels

---

*This analysis is for informational purposes only and does not constitute financial advice.
Options trading involves significant risk of loss. Past performance is not indicative of future results.*
